Rare diseases
Investigational molecules
Locations
830 Winter Street Suite 2, 02451-1477, United States
Clinical research is centered on moderate to severe atopic dermatitis, with attention to symptoms, disease control, and treatment response in affected patients.
The sponsor’s trial activity in this area reflects an interest in therapies aimed at improving skin inflammation and related patient burden.
Q32 Bio Inc. runs clinical trials in conditions such as Dermatitis atopic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
